DKSH has signed an agreement to acquire Medipharm, enhancing its presence in Brunei's pharmaceutical distribution market.

Information on the Target

Medipharm is a prominent distributor of pharmaceuticals and medical devices in Brunei, boasting over 25 years of experience as a sub distributor for DKSH. The company generates net sales exceeding CHF 30 million and employs a workforce of more than 50 people. Medipharm caters to a diverse clientele, including hospitals, medical centers, clinics, opticians, and pharmacies, providing a wide range of products such as pharmaceuticals, medical devices, consumer health items, personal care, and nutritional products.

Since its establishment in 1998, Medipharm has played a crucial role in connecting clients with customers for the distribution of essential medical products. The recent acquisition by DKSH represents a significant milestone in Medipharm's growth journey, aiming to enhance service delivery and expand market reach.

Industry Overview in Brunei

The healthcare sector in Brunei is characterized by a mix of public and private medical services, with the government heavily investing in health infrastructure. This investment has led to improvements in